Terms: = Kidney tumors AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825
12297 results:
1. Molecular and functional characterization of reversible-sunitinib-tolerance state in human renal cell carcinoma.
Zaccagnino A; Vynnytska-Myronovska B; Stöckle M; Junker K
J Cell Mol Med; 2024 May; 28(9):e18329. PubMed ID: 38693863
[TBL] [Abstract] [Full Text] [Related]
2. SCPLPA: An miRNA-disease association prediction model based on spatial consistency projection and label propagation algorithm.
Chen M; Deng Y; Li Z; Ye Y; Zeng L; He Z; Peng G
J Cell Mol Med; 2024 May; 28(9):e18345. PubMed ID: 38693850
[TBL] [Abstract] [Full Text] [Related]
3. Radiolabelled FGF-2 for Imaging Activated Fibroblasts in the Tumor Micro-Environment.
Bentivoglio V; Galli F; Varani M; Ranieri D; Nayak P; D'Elia A; Soluri A; Massari R; Lauri C; Signore A
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672507
[TBL] [Abstract] [Full Text] [Related]
4. Overexpression of cyclin F/CCNF as an independent prognostic factor for poor survival in clear cell renal cell carcinoma.
Kwiatkowski M; Krajewski A; Durślewicz J; Buchholz K; Grzanka D; Gagat M; Zabrzyński J; Klimaszewska-Wiśniewska A
Sci Rep; 2024 Apr; 14(1):9280. PubMed ID: 38654021
[TBL] [Abstract] [Full Text] [Related]
5. The development of chimeric antigen receptor T-cells against CD70 for renal cell carcinoma treatment.
Xiong Q; Wang H; Shen Q; Wang Y; Yuan X; Lin G; Jiang P
J Transl Med; 2024 Apr; 22(1):368. PubMed ID: 38637886
[TBL] [Abstract] [Full Text] [Related]
6. Multi-omics and immunogenomics analysis revealed PFKFB3 as a targetable hallmark and mediates sunitinib resistance in papillary renal cell carcinoma: in silico study with laboratory verification.
Lu Z; Pan Y; Wang S; Wu J; Miao C; Wang Z
Eur J Med Res; 2024 Apr; 29(1):236. PubMed ID: 38622715
[TBL] [Abstract] [Full Text] [Related]
7. VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis.
Wolf MM; Madden MZ; Arner EN; Bader JE; Ye X; Vlach L; Tigue ML; Landis MD; Jonker PB; Hatem Z; Steiner KK; Gaines DK; Reinfeld BI; Hathaway ES; Xin F; Tantawy MN; Haake SM; Jonasch E; Muir A; Weiss VL; Beckermann KE; Rathmell WK; Rathmell JC
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618956
[TBL] [Abstract] [Full Text] [Related]
8. Pazopanib stimulates senescence of renal carcinoma cells through targeting nuclear factor E2-related factor 2 (Nrf2).
Wang X; Yang J; Li D; Teng L; Chen Y; Meng J; Yang C; Yin Z; Li C
J Biochem Mol Toxicol; 2024 Apr; 38(4):e23689. PubMed ID: 38613465
[TBL] [Abstract] [Full Text] [Related]
9. The application strategy of liposomes in organ targeting therapy.
Xun Z; Li T; Xue X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1955. PubMed ID: 38613219
[TBL] [Abstract] [Full Text] [Related]
10. Boosting Clear Cell Renal Carcinoma-Specific Drug Discovery Using a Deep Learning Algorithm and Single-Cell Analysis.
Wang Y; Chen X; Tang N; Guo M; Ai D
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612943
[TBL] [Abstract] [Full Text] [Related]
11. ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.
Huang Y; Chen D; Bai Y; Zhang Y; Zheng Z; Fu Q; Yi B; Jiang Y; Zhang Z; Zhu J
BMC Cancer; 2024 Apr; 24(1):452. PubMed ID: 38605349
[TBL] [Abstract] [Full Text] [Related]
12. PMab-314: An Anti-Giant Panda Podoplanin Monoclonal Antibody.
Ouchida T; Li G; Suzuki H; Yanaka M; Nakamura T; Handa S; Tanaka T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2024 Apr; 43(2):53-58. PubMed ID: 38593441
[TBL] [Abstract] [Full Text] [Related]
13. MiR-574-5p activates human TLR8 to promote autoimmune signaling and lupus.
Wang T; Song D; Li X; Luo Y; Yang D; Liu X; Kong X; Xing Y; Bi S; Zhang Y; Hu T; Zhang Y; Dai S; Shao Z; Chen D; Hou J; Ballestar E; Cai J; Zheng F; Yang JY
Cell Commun Signal; 2024 Apr; 22(1):220. PubMed ID: 38589923
[TBL] [Abstract] [Full Text] [Related]
14. PDCD4-induced oxidative stress through FGR/NF-κB axis in rectal cancer radiotherapy-induced AKI.
Ma Q; Zheng L; Cheng H; Li X; Liu Z; Gong P
Int Immunopharmacol; 2024 May; 132():111779. PubMed ID: 38581987
[TBL] [Abstract] [Full Text] [Related]
15. Mesenchymal glioma stem cells trigger vasectasia-distinct neovascularization process stimulated by extracellular vesicles carrying EGFR.
Spinelli C; Adnani L; Meehan B; Montermini L; Huang S; Kim M; Nishimura T; Croul SE; Nakano I; Riazalhosseini Y; Rak J
Nat Commun; 2024 Apr; 15(1):2865. PubMed ID: 38570528
[TBL] [Abstract] [Full Text] [Related]
16. An ecological analysis of associations between ambient air pollution and cancer incidence rates in Taiwan.
Cheng SY; Hsu YC; Cheng SP
Environ Sci Pollut Res Int; 2024 Apr; 31(20):29162-29173. PubMed ID: 38565820
[TBL] [Abstract] [Full Text] [Related]
17. Establishment of a Novel Cancer-Specific Anti-HER2 Monoclonal Antibody H
Kaneko MK; Suzuki H; Kato Y
Monoclon Antib Immunodiagn Immunother; 2024 Apr; 43(2):35-43. PubMed ID: 38563783
[TBL] [Abstract] [Full Text] [Related]
18. Post molar choriocarcinoma with solitary renal metastasis in the absence of primary uterine tumor: a case report and review of the literature.
Geravandi M; Hajihashemi A; Adibi A; Habibi Tirtashi R
J Med Case Rep; 2024 Mar; 18(1):132. PubMed ID: 38553733
[TBL] [Abstract] [Full Text] [Related]
19. First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid tumors.
Yarchoan M; Powderly JD; Bastos BR; Karasic TB; Crysler OV; Munster PN; McKean MA; Emens LA; Saenger YM; Ged Y; Stagg R; Smith S; Whiting CC; Moon A; Prasit P; Jenkins Y; Standifer N; Dubensky TW; Whiting SH; Ulahannan SV
Cancer Res Commun; 2024 Apr; 4(4):1100-1110. PubMed ID: 38551394
[TBL] [Abstract] [Full Text] [Related]
20. Safety of Docetaxel in a Patient with Metastatic Castration-Resistant Prostate Cancer After kidney Transplantation: A Case Report.
Nagahisa C; Iizuka J; Kobari Y; Minoda R; Oki R; Unagami K; Yoshida K; Hirai T; Omoto K; Shimizu T; Ishida H; Takagi T
Transplant Proc; 2024 Apr; 56(3):729-733. PubMed ID: 38548511
[TBL] [Abstract] [Full Text] [Related]
[Next]